José Luis Mauriz (Jose L Mauriz, José L Mauriz)

ResearcherID Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Cancers

Nutrients

Cells

Clinical pharmacology and therapeutics

Universidad de León

Universidad de León (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de León Apr 13 2018

Spain

Head :: Institute of Biomedicine -IBIOMED-

Universidad de León

Spain

Professor and Senior Research :: Biomedical Sciencies and Institute of Biomedicine

Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas

Spain

Researcher

INSERM

France

Postdoctoral Researcher :: Unit on mechanisms and traitments of liver diseases. Hospital Bichat-Claude Bernard

Education History

Universidad de León

Spain

PHD

Universidad de León

Spain

MSC

Publications

Irene Crespo, Beatriz San-Miguel, José Luis Mauriz, Juan José Ortiz de Urbina, Mar Almar, María Jesús Tuñón, Javier Gonzalez-Gallego
Correction: Crespo et al. Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway. Nutrients 2017, 9 , 288. Nutrients 16 (6) (2024)
Irene Crespo, Beatriz San-Miguel, José Luis Mauriz, Juan José Ortiz de Urbina, Mar Almar, María Jesús Tuñón, Javier Gonzalez-Gallego
Correction: Crespo et al. Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway. Nutrients 2017, 9 , 288. Nutrients 16 (6) (2024)
Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics 116 (2) (2024)
Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics (2024)
Elisa Lozano, Paula Sanchon-Sanchez, Ana Morente-Carrasco, Luis Miguel Chinchilla-Tábora, José Luis Mauriz, Paula Fernández-Palanca, Jose J G Marin, Rocío I R Macías
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. Cells 12 (8) (2023)
Elisa Lozano, Paula Sanchon-Sanchez, Ana Morente-Carrasco, Luis Miguel Chinchilla-Tábora, José Luis Mauriz, Paula Fernández-Palanca, Jose J G Marin, Rocío I R Macías
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. Cells 12 (8) (2023)
Elisa Lozano, Paula Sanchon-Sanchez, Ana Morente-Carrasco, Luis Miguel Chinchilla-Tábora, José Luis Mauriz, Paula Fernández-Palanca, Jose J G Marin, Rocío I R Macías
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. Cells 12 (8) (2023)
Carolina Méndez-Blanco, Flavia Fondevila, Paula Fernández-Palanca, Andrés García-Palomo, Jos van Pelt, Chris Verslype, Javier Gonzalez-Gallego, José Luis Mauriz
Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. Cancers 2019, 11 , 1984. Cancers 15 (23) (2023)
Jose J G Marin, Maria J Monte, Rocío I R Macías, Marta R Romero, Elisa Herráez, Maitane Asensio, Sara Ortiz-Rivero, Candela Cives-Losada, Silvia Di Giacomo, Javier Gonzalez-Gallego, José Luis Mauriz, Thomas Efferth, Oscar Briz
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers. Cancers 14 (14) (2022)
Beatriz San-Miguel, Paula Fernández-Palanca, José Luis Mauriz, María Jesús Tuñón, Javier Gonzalez-Gallego
Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence. Journal of cellular physiology 237 (7) (2022)
Paula Fernández-Palanca, Tania Payo-Serafín, Flavia Fondevila, Carolina Méndez-Blanco, Beatriz San-Miguel, Marta R Romero, María Jesús Tuñón, Jose J G Marin, Javier Gonzalez-Gallego, José Luis Mauriz
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies. Cancers 14 (14) (2022)
Carolina Méndez-Blanco, Paula Fernández-Palanca, Flavia Fondevila, Javier Gonzalez-Gallego, José Luis Mauriz
Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis. Therapeutic advances in medical oncology 13 (2021)
Flavia Fondevila, Paula Fernández-Palanca, Carolina Méndez-Blanco, Tania Payo-Serafín, Elisa Lozano, Jose J G Marin, Javier Gonzalez-Gallego, José Luis Mauriz
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 13 (21) (2021)
Paula Fernández-Palanca, Carolina Méndez-Blanco, Flavia Fondevila, María Jesús Tuñón, Russel Joseph Reiter, José Luis Mauriz, Javier Gonzalez-Gallego
Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review. Antioxidants (Basel, Switzerland) 10 (1) (2021)
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Tania Payo-Serafín, Jos van Pelt, Chris Verslype, Javier Gonzalez-Gallego, José Luis Mauriz
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. International journal of molecular sciences 22 (21) (2021)
Paula Fernández-Palanca, Flavia Fondevila, Carolina Méndez-Blanco, María Jesús Tuñón, Javier Gonzalez-Gallego, José Luis Mauriz
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review. Nutrients 11 (12) (2019)
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Javier Gonzalez-Gallego, José Luis Mauriz
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers. Experimental & molecular medicine 51 (9) (2019)
Carolina Méndez-Blanco, Flavia Fondevila, Andrés García-Palomo, Javier Gonzalez-Gallego, José Luis Mauriz
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Experimental & molecular medicine 50 (10) (2018)

José Luis Mauriz.css-eqlu8i{font-size:small;padding-left:4px;} (Jose L Mauriz, José L Mauriz)

Publication Activity (10 Years)

Top Topics

Top Venues

José Luis Mauriz (Jose L Mauriz, José L Mauriz)